Dellamonica P - Search Results

1

A decreasing CD4/CD8 ratio over time and lower CSF-penetrating antiretroviral regimens are associated with a higher risk of neurocognitive deterioration, independently of viral replication.

Vassallo M, Fabre R, Durant J, Lebrun-Frenay C, Joly H, Ticchioni M, DeSalvador F, Harvey-Langton A, Dunais B, Laffon M, Cottalorda J, Dellamonica P, Pradier C. Vassallo M, et al. Among authors: dellamonica p. J Neurovirol. 2017 Apr;23(2):216-225. doi: 10.1007/s13365-016-0490-z. Epub 2016 Nov 4. J Neurovirol. 2017. PMID: 27815816

2

Virologically suppressed patients with asymptomatic and symptomatic HIV-associated neurocognitive disorders do not display the same pattern of immune activation.

Vassallo M, Durant J, Lebrun-Frenay C, Fabre R, Ticchioni M, Andersen S, DeSalvador F, Harvey-Langton A, Dunais B, Cohen-Codar I, Montagne N, Cua E, Fredouille-Heripret L, Laffon M, Cottalorda J, Dellamonica P, Pradier C. Vassallo M, et al. Among authors: dellamonica p. HIV Med. 2015 Aug;16(7):431-40. doi: 10.1111/hiv.12246. Epub 2015 May 18. HIV Med. 2015. PMID: 25981452 Free article.

3

Do viral load and CD8 cell count at initiation of tritherapy influence the increase of CD4 T-cell count?

Keita-Perse O, Roger PM, Pradier C, Pugliese P, Cottalorda J, Dellamonica P. Keita-Perse O, et al. Among authors: dellamonica p. AIDS. 1998 Oct 22;12(15):F175-9. doi: 10.1097/00002030-199815000-00002. AIDS. 1998. PMID: 9814859

4

Effect of indinavir and higher CD4+ T-cell count on viral load response after 6 months of highly active antiretroviral therapy.

Pradier C, Pesce A, Carrieri P, Cottalorda J, Boyer P, Senesi C, Fuzibet JG, Dellamonica P, Cassuto JP. Pradier C, et al. Among authors: dellamonica p. Clin Ther. 1999 Aug;21(8):1313-20. doi: 10.1016/s0149-2918(99)80032-0. Clin Ther. 1999. PMID: 10485503

5

Persistent viral load in patients on HAART is associated with a higher level of activation-induced apoptosis of CD4(+) T cells.

Roger PM, Breittmayer JP, Cottalorda J, Ticchioni M, Mondain V, Dellamonica P, Bernard A. Roger PM, et al. Among authors: dellamonica p. J Antimicrob Chemother. 2001 Jan;47(1):109-12. doi: 10.1093/jac/47.1.109. J Antimicrob Chemother. 2001. PMID: 11152441

6

[Antiretroviral therapies: strategic perspectives for the future].

Dellamonica P, Pugliese P, Durant J. Dellamonica P, et al. Med Trop (Mars). 2007 Aug;67(4):363-6. Med Trop (Mars). 2007. PMID: 17926795 French.

7

[Non-typhoid salmonellosis in HIV infection].

Dellamonica P, Pradier C. Dellamonica P, et al. Rev Prat. 1992 Nov 15;42(18):2283-4. Rev Prat. 1992. PMID: 1296293 French.

8

[Mechanisms of lymphopenia in HIV infection].

Roger PM, Pradier C, Dellamonica P. Roger PM, et al. Among authors: dellamonica p. Presse Med. 1994 Jan 22;23(2):89-94. Presse Med. 1994. PMID: 7908132 Review. French.

9

[Immunomodulator treatments in HIV infection: rational bases and therapeutic prospects].

Durant J, Dellamonica P. Durant J, et al. Among authors: dellamonica p. Rev Med Interne. 1995;16 Suppl 3:308s-312s. doi: 10.1016/0248-8663(96)80867-8. Rev Med Interne. 1995. PMID: 8570969 Review. French. No abstract available.

10

In the era of highly active antiretroviral therapy, why are HIV-infected patients still admitted to hospital for an inaugural opportunistic infection?

Perbost I, Malafronte B, Pradier C, Santo LD, Dunais B, Counillon E, Vinti H, Enel P, Fuzibet JG, Cassuto JP, Dellamonica P. Perbost I, et al. Among authors: dellamonica p. HIV Med. 2005 Jul;6(4):232-9. doi: 10.1111/j.1468-1293.2005.00282.x. HIV Med. 2005. PMID: 16011527 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

535 results

Search Page

Filters